News

A research team has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of ...
A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...
Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.
A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Kindai University Faculty of Medicine, in collaboration with the Faculty of Engineering at ...
Nemluvio was well tolerated and showed sustained improvements in moderate to severe prurigo nodularis during a 2-year ...
A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Kindai University Faculty of Medicine, in ...
Cambridge Investment Research Advisors Inc. boosted its holdings in Journey Medical Corporation (NASDAQ:DERM – Free Report) ...
Dr. Vlada Groysman of Cahaba Dermatology is the ONLY vulvar dermatologist in the Southeast. Get to know this trailblazing ...
DERM (Deep Ensemble for Recognition of Malignancy), which was approved in the UK as a Class IIA medical device in 2022, analyses images to assess and triage skin lesions, and may be able to refer ...
A high-level overview of Journey Medical Corporation (DERM) stock. View (DERM) real-time stock price, chart, news, analysis, analyst reviews and more.
Your brain and skin are interconnected—and when a disorder affects both, treatment must involve a multidisciplinary approach.